Allworth Financial’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.05K | Buy |
249
+127
| +104% | +$4.62K | ﹤0.01% | 2937 |
|
|
2025
Q1 | $4.59K | Buy |
122
+105
| +618% | +$3.95K | ﹤0.01% | 2801 |
|
|
2024
Q4 | $730 | Hold |
17
| – | – | ﹤0.01% | 3492 |
|
|
2024
Q3 | $945 | Hold |
17
| – | – | ﹤0.01% | 3238 |
|
|
2024
Q2 | $724 | Sell |
17
-2
| -11% | -$85 | ﹤0.01% | 3269 |
|
|
2024
Q1 | $888 | Buy |
19
+12
| +171% | +$561 | ﹤0.01% | 3120 |
|
|
2023
Q4 | $335 | Sell |
7
-33
| -83% | -$1.58K | ﹤0.01% | 3217 |
|
|
2023
Q3 | $1.43K | Buy |
40
+29
| +264% | +$1.03K | ﹤0.01% | 2697 |
|
|
2023
Q2 | $508 | Buy |
11
+7
| +175% | +$323 | ﹤0.01% | 2898 |
|
|
2023
Q1 | $161 | Sell |
4
-10
| -71% | -$403 | ﹤0.01% | 3052 |
|
|
2022
Q4 | $649 | Buy |
14
+9
| +180% | +$417 | ﹤0.01% | 2565 |
|
|
2022
Q3 | $0 | Buy |
+5
| New | – | ﹤0.01% | 3030 |
|
|
2022
Q2 | – | Sell |
-11
| Closed | -$1K | – | 2731 |
|
|
2022
Q1 | $1K | Sell |
11
-97
| -90% | -$8.82K | ﹤0.01% | 1996 |
|
|
2021
Q4 | $9K | Sell |
108
-3
| -3% | -$250 | ﹤0.01% | 1419 |
|
|
2021
Q3 | $10K | Buy |
+111
| New | +$10K | ﹤0.01% | 1344 |
|